Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sacubitril/Valsartan in CKD5 Dialysis Patients
NCT05243199Phase 4Completed
- Sponsor
- Ruijin Hospital
- Start
- Aug 2020
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sacubitril + valsartan in hypertension (HTN), heart failure (HF), sponsored by Ruijin Hospital. Started Aug 2020; status: completed.
02
Drugs
sacubitril + valsartan
03
Conditions
hypertension (HTN)heart failure (HF)
Beyond the preview
Go deeper on NCT05243199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05243199.